Rada J A, Achen V R, Rada K G
Department of Anatomy and Cell Biology, University of North Dakota School of Medicine and Health Sciences, Grand Forks 58202, USA.
Invest Ophthalmol Vis Sci. 1998 Oct;39(11):1990-2002.
The turnover of chick scleral proteoglycans from control and form-vision deprived (myopic) eyes was compared in vivo and in explant cultures to determine whether proteoglycan degradation is altered during the development of myopia and to characterize the mechanism of proteoglycan turnover in the sclera.
Seven-day-old chicks were radiolabeled via an intraperitoneal injection of 35SO4, and monocular form deprivation was induced 48 hours later. After 1, 2, and 3 weeks of form deprivation, birds were killed, and the amount of 35SO4-proteoglycans remaining in different scleral regions was measured in control and deprived eyes. Posterior sclera were also radiolabeled in organ culture containing 35SO4, and radiolabeled scleral proteoglycans were chased into unlabeled medium for 0 to 11 days. 35SO4-labeled proteoglycans within the scleral matrix and those released into the medium were characterized by Sepharose CL-2B chromatography and western blot analysis.
The biological half-life of scleral proteoglycans was significantly shorter within the posterior pole of form-deprived eyes (t1/2 = 7.212 days) compared with the same region of control eyes (t1/2 = 9.619 days; P < 0.001), whereas no differences in turnover rates were seen in the anterior sclera or equatorial sclera. When posterior scleral punches were placed in organ culture, 35SO4-labeled proteoglycan turnover rates were similar for control and form-deprived eyes. Chromatographic and western blot analyses indicated that approximately 80% of the total 35SO4 within the posterior sclera is incorporated into the aggrecan. Western blot analyses of aggrecan core protein released into the medium by control and form-deprived scleral punches indicated that the core protein was degraded into a series of smaller fragments of Mr = 102 to 220 kDa. A specific antiserum (anti-FVDIPEN) detected the presence of a 50-kDa C-terminal aggrecan fragment released into the medium, which was generated by the action of the matrix metalloproteinase gelatinase A and/or stromelysin.
The turnover rate of 35SO4-labeled scleral proteoglycans is vision dependent and is accelerated in the posterior sclera of chick eyes during the development of experimental myopia. The loss of proteoglycans from the scleral matrix involves proteolytic cleavage at various sites along the aggrecan core protein through the action, at least in part, of gelatinase A and/or stromelysin.
在体内和外植体培养中比较来自对照和形觉剥夺(近视)眼的鸡巩膜蛋白聚糖的更新情况,以确定在近视发展过程中蛋白聚糖降解是否发生改变,并阐明巩膜中蛋白聚糖更新的机制。
通过腹腔注射35SO4对7日龄雏鸡进行放射性标记,48小时后诱导单眼形觉剥夺。在形觉剥夺1、2和3周后,处死雏鸡,测量对照眼和剥夺眼不同巩膜区域中剩余的35SO4标记的蛋白聚糖量。后巩膜也在含有35SO4的器官培养中进行放射性标记,将放射性标记的巩膜蛋白聚糖在未标记的培养基中追踪0至11天。通过琼脂糖CL-2B层析和蛋白质印迹分析对巩膜基质中以及释放到培养基中的35SO4标记的蛋白聚糖进行表征。
与对照眼的相同区域(t1/2 = 9.619天;P < 0.001)相比,形觉剥夺眼后极部巩膜蛋白聚糖的生物学半衰期显著缩短(t1/2 = 7.212天),而在前部巩膜或赤道部巩膜中未观察到更新率的差异。当将后巩膜组织块置于器官培养中时,对照眼和形觉剥夺眼的35SO4标记的蛋白聚糖更新率相似。层析和蛋白质印迹分析表明,后巩膜中总35SO4的约80%掺入聚集蛋白聚糖中。对对照和形觉剥夺的巩膜组织块释放到培养基中的聚集蛋白聚糖核心蛋白进行蛋白质印迹分析表明,核心蛋白被降解为一系列Mr = 102至220 kDa的较小片段。一种特异性抗血清(抗FVDIPEN)检测到释放到培养基中的50 kDa聚集蛋白聚糖C末端片段的存在,并证实该片段是由基质金属蛋白酶明胶酶A和/或基质溶素作用产生的。
35SO4标记的巩膜蛋白聚糖的更新率依赖于视觉,并且在实验性近视发展过程中鸡眼后巩膜中的更新加速。巩膜基质中蛋白聚糖的丢失涉及聚集蛋白聚糖核心蛋白沿不同位点的蛋白水解切割,至少部分是通过明胶酶A和/或基质溶素的作用。